SCHEMBL27489015

SCHEMBL27489015

NC(N)=NC(=O)c1ccccc1.[NaH]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 1/20 0.53
CYP2C19 P33261 2/20 0.52
POLB P06746 1/20 0.52
CYP3A4 P08684 1/20 0.52
PARP1 P09874 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
HTR2B P41595 9/20 0.51
HTR7 P34969 7/20 0.51
SLC9A1 P19634 2/20 0.49
DRD2 P14416 1/20 0.49
ADRA1D P25100 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL828587 0.98 TPH1 (0.55) TPH1CYP2C19POLBCYP3A4PARP1
Hydrochloric Acid SCHEMBL27319279 0.95 TPH1 (0.53) TPH1CYP2C19POLBCYP3A4PARP1
Hydrochloric Acid SCHEMBL27296270 0.95 TPH1 (0.53) TPH1CYP2C19POLBCYP3A4PARP1
SCHEMBL5441718 0.85 SLC9A1 (0.53) TPH1MAPTHTR2BHTR7SLC9A1
Hydrochloric Acid SCHEMBL7824640 0.84 SLC9A1 (0.51) TPH1MAPTHTR2BHTR7SLC9A1
SCHEMBL17008170 0.82 POLB (0.52) CYP2C19POLBCYP3A4PARP1MAPT
SCHEMBL1387930 0.81 KMO (0.56) HTR2BHTR7SLC9A1DRD2ADRA1D
SCHEMBL5434684 0.81 PARP10 (0.65) TPH1HTR2BHTR7SLC9A1
SCHEMBL15336489 0.80 CYP2C19 (0.50) TPH1CYP2C19POLBCYP3A4PARP1
SCHEMBL15320289 0.80 CYP2C19 (0.50) TPH1CYP2C19POLBCYP3A4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100475813-C 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2009-04-08 CN disclosed
CN-100422175-C Tetracyclic imidazole derivatives as metabotropic glutamate receptor-5 modulators MERCK & CO INC (US) 2008-10-01 CN disclosed
CN-100387594-C Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO INC (US) 2008-05-14 CN disclosed
CN-100338061-C Alkyne-aryl phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2007-09-19 CN disclosed
CN-1933838-A Bipyridyl amides as modulators of metabotropic glutamate receptor-5 MERCK & CO INC (US) 2007-03-21 CN disclosed
CN-1845915-A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 MERCK & CO INC (US) 2006-10-11 CN disclosed
CN-1795184-A Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO INC (US) 2006-06-28 CN disclosed
CN-1768055-A Fourth Ring imdazole derivatives as the metabotropic glutamate receptor-5 modulator MERCK & CO INC (US) 2006-05-03 CN disclosed
CN-1738819-A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2006-02-22 CN disclosed
CN-1221534-C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2005-10-05 CN disclosed
CN-1211383-C Process for preparing substituted 8-arylquinolinium benzenesulfonates MERCK & CO INC (US) 2005-07-20 CN disclosed
CN-1639161-A Alkyne-aryl phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2005-07-13 CN disclosed
CN-1483032-A Process for preparing substituted 8-arylquinolinium benzenesulfonates 2004-03-17 CN disclosed
CN-1434801-A Substited 8-anylquinoline phosphodiesterase-4 inhibitors MERCK FROSST CANADA INC (CA) 2003-08-06 CN disclosed